Krónikus obstruktív tüdőbetegség (COPD): vizsgálatok itt: Japán

13 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

• 2. fázisTaking people
  A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

  Where

  Chūōku, Fukuoka, Iizuka, Osaka, Sendai, Ube

  Életkor

  40 év to 75 év

  People

  606 worldwide

  Run by

  Eli Lilly and Company

  See details and how to joinNCT07759245 · EU 2026-525480-41-00
• 3. fázisTaking people
  A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)

  Where

  Fukuoka, Tokyo

  Életkor

  40 év to 80 év

  People

  624 worldwide

  Run by

  GlaxoSmithKline

  See details and how to joinNCT07780669
• 2. fázisTaking people
  A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

  Where

  Chiba, Fukuoka, Fukushima, Ginowan-shi, Hachioji-shi, Hamamatsu, Hiroshima, Izumi-shi, Kamakura, Kanazawa, Kasuga-shi, Kawasaki-shi, Kiyosu-shi, Kochi, Kōtoku, Kumamoto, Kusatsu-shi, Kyoto, Maebashi, Matsuyama, Minoh, Minokamo Shi, Miura, Mizunami-shi, Ōita, Osaka, Sagamihara-shi, Sapporo, Sasebo-shi, Shimotsuga-gun, Shinjuku-ku, Tachikawa-shi, Toon-Shi, Toyota, Ube, Yokkaichi-shi, Yokohama

  Életkor

  40 év and over

  People

  987 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07082738
• 2/3. fázisTaking people
  A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

  Where

  Fujieda, Fukuoka, Ginowan, Hachiōji, Hiroshima, Iizuka-shi, Kure, Nagoya, Sakai, Ube

  Életkor

  35 év to 80 év

  People

  1156 worldwide

  Run by

  Pfizer

  See details and how to joinNCT07363694 · EU 2024-518587-12-00
• 4. fázisTaking people
  A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

  Where

  Kyoto, Osaka, Ube

  Életkor

  40 év to 85 év

  People

  218 worldwide

  Run by

  Sanofi

  See details and how to joinNCT07053423
• 3. fázisTaking people
  Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

  Where

  Chiba, Fujieda, Fukuoka, Fukushima, Hachiōji, Himeji-Shi, Hiroshima, Iizuka, Kagoshima, Kamakura, Kashihara, Kawasaki, Kita, Kiyose, Kobe, Kōnan, Kumamoto, Kure, Kurume, Kyoto, Matsusaka, Matsuyama, Nagoya, Okayama, Osaka, Saga, Sakai, Sakaidechō, Sapporo, Sendai, Takamatsu, Tokyo, Toyota, Ube, Ureshino-Shi, Yokohama, Yonezawa

  Életkor

  40 év to 80 év

  People

  942 worldwide

  Run by

  Sanofi

  See details and how to joinNCT07190209 · EU 2024-518016-39-00
• 3. fázisTaking people
  A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

  Where

  Akashi-shi, Chikushino-shi, Chiyoda-ku, Fukui-shi, Fukuoka, Gifu, Iruma-Gun, Ishinomaki, Kasuga-shi, Kitakyushu-shi, Kiyose-shi, Kobe, Komatsu-shi, Kure-shi, Kyoto, Matsusaka-shi, Meguro-ku, Minatoku, Miyazaki, Mizunami-shi, Nagaoka-shi, Nagasaki, Nagoya, Nerima-ku, Ohta-ku, Okayama, Osaka, Sapporo, Sendai, Shinjuku-ku, Shiogama, Takamatsu, Takatsuiki-shi, Tanabe-shi, Toshima-ku, Ube, Yokohama

  Életkor

  40 év to 80 év

  People

  990 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT06878261 · EU 2024-517457-27-00
• 3. fázisTaking people
  Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation

  Where

  Chiba, Fukuoka, Fukushima, Gifu, Hokkaido, Hyōgo, Ibaraki, Ishikawa, Kagawa, Kanagawa, Kitakyushu-shi, Kyoto, Mie, Nankoku-shi, Niigata, Okayama, Omuta Shi, Osaka, Shizuoka, Tokyo, Yamaguchi, Yokohama

  Életkor

  40 év to 80 év

  People

  981 worldwide

  Run by

  GlaxoSmithKline

  See details and how to joinNCT06959095 · EU 2024-520418-22-00
• 3. fázisTaking people
  A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

  Where

  Chūōku, Fujieda-shi, Fukuoka, Kitakyushu, Kobe, Kure-shi, Kyoto, Minoh, Mizunami-shi, Okayama, Osaka, Osaki-shi, Sendai, Shinjuku-ku, Takamatsu, Yamagata, Yanagawa-shi, Yokohama

  Életkor

  40 év to 80 év

  People

  5250 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT06283966 · EU 2023-507407-59-00
• No phaseTaking people
  Zephyr Valve Japan Post-Marketing Surveillance

  Where

  Aichi, Gifu, Kanagawa, Kanazawa, Kawasaki, Mie, Nagasaki, Nagoya, Okayama, Osaka, Sapporo, Sendai, Shiga, Tokyo, Toyoake, Utsunomiya

  Életkor

  18 év and over

  People

  140

  Run by

  Pulmonx Corporation

  See details and how to joinNCT06332885
• 3. fázisTaking people
  eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

  Where

  Gifu, Mie, Tokyo

  Életkor

  40 év to 75 év

  People

  1196 worldwide

  Run by

  GlaxoSmithKline

  See details and how to joinNCT07177339 · EU 2025-521108-23-00
• No phaseNot yet taking people in Japán
  Improvement of Sleep in COPD Patients Through Inhalation Management Education by Nurse.

  Where

  Kumamoto

  Életkor

  20 év and over

  People

  60

  Run by

  Kumamoto University

  See details and how to joinNCT07311499
• No phaseTaking people
  Sleep Hygiene, Sarcopenia, and Cognitive Function in Respiratory Disease

  Where

  Jōyō

  Életkor

  20 év and over

  People

  120

  Run by

  National Hospital Organization Minami Kyoto Hospital

  See details and how to joinNCT05193136